Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
Today is March 29, 2024. All times in Eastern Daylight Time.
Genzyme Receives Complete Response Letter on Lumizyme Application
11/16/2009 - 09:17 AM
Genzyme Issues Letters to U.S. Healthcare Providers
11/13/2009 - 05:10 PM
Genzyme Reports Third-Quarter Financial Results
10/21/2009 - 09:07 AM
First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease
10/20/2009 - 02:01 PM
Scientists Name Genzyme a Top Employer
10/14/2009 - 12:06 PM
Genzyme Receives FDA Complete Response Letter for Clolar
10/06/2009 - 01:15 PM
Genzyme Named to Dow Jones Sustainability World and North American Indexes
10/02/2009 - 09:00 AM
Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia
09/24/2009 - 08:30 AM
Genzyme Provides Update on Cerezyme and Fabrazyme Supply
09/23/2009 - 08:49 AM
Genzyme’s Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data
09/11/2009 - 11:44 AM
FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML
09/01/2009 - 03:34 PM
FDA Advisory Committee to Discuss Genzyme’s Clolar for Adult AML on September 1
08/28/2009 - 12:22 PM
Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
08/10/2009 - 01:13 PM
European Commission Approves Genzyme’s Mozobil
08/05/2009 - 08:00 AM
Genzyme Provides Update on Allston Landing Plant
07/31/2009 - 11:31 AM
Genzyme Delivers Solid Second-Quarter Financial Results
07/22/2009 - 09:04 AM
Genzyme Reports Progress Related to Allston Plant
06/25/2009 - 11:30 AM
Genzyme Temporarily Interrupts Production at Allston Plant
06/16/2009 - 08:30 AM
Genzyme Receives European Approval of Renvela for Patients with Chronic Kidney Disease
06/12/2009 - 09:00 AM
Genzyme Completes Transaction with Bayer HealthCare
06/02/2009 - 08:00 AM
Genzyme Receives Positive Opinion for European Approval of Mozobil
05/29/2009 - 01:15 PM
Genzyme Submits All Information Requested by FDA for Lumizyme
05/21/2009 - 11:57 AM
Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
05/20/2009 - 09:00 AM
Genzyme Provides Outlook for Long-Term Growth at its Analyst Day Meeting
05/06/2009 - 01:40 PM
Genzyme Reports Solid Financial Results for the First Quarter of 2009
04/22/2009 - 08:55 AM
1
2
3
4
5
6
7
8
9
10
11
« Previous
Next »
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG